Grants8

Grant Information	Key Details	Eligibility & Funding
Minor Use Minor Species Development of Drugs (R01) PAR-24-216 Programme: FDA Grants	This grant from the U.S. Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), aims to support research and development of new animal drugs for 'minor uses in major species' or for 'minor animal species' (MUMS drugs). It provides funding for qualified safety and effectiveness testing required for FDA approval or conditional approval of these designated veterinary drugs. - Target recipients: Institutions or organizations, or their research partners, developing MUMS animal drugs. - Target size: Not specified by size, but by role in drug development. - SECTOR-SPECIFIC: Animal Health, Veterinary Medicine, Pharmaceutical Research (Veterinary). - Geographic scope: Domestic (U.S.) and non-domestic (non-U.S.) entities are eligible. - Key filtering criteria: Must have an Investigational New Animal Drug (INAD) file with FDA/CVM, hold a MUMS 'designation' for the drug, and have FDA/CVM/ONADE concurrence on the proposed study protocol. - Grant frequency and program context: This is a recurring R01 Research Project Grant opportunity with multiple application due dates annually until January 2027. It stems from the 'Minor Use and Minor Species Animal Health Act of 2004' (MUMS Act) to increase availability of medications for less common animal health needs.	Funding Up to 750000.00 USD Deadline Jan. 30, 2027, 4:59 a.m.	Details
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) PAR-21-321 Programme: P30 Center Core Grants	Grant Purpose and Target Core Objective: Foster excellence in cancer research and facilitate the translation of scientific discoveries into improved prevention, diagnosis, and therapy by supporting NCI-designated Cancer Centers. Target Recipient Type and Size: Established NCI-designated Cancer Centers or institutions with substantial existing cancer research funding aiming for NCI designation. Designation: SECTOR-SPECIFIC (Healthcare/Cancer Research). Geographic Scope and Location Requirements: Limited to institutions within the United States. Key Filtering Criteria: Applicant must be a research institution with a significant existing base of NIH-funded cancer-focused research ($6,000,000 or $10,000,000 in direct annual costs, depending on Center type), or be an existing NCI-designated Cancer Center. Grant Frequency and Program Context: This is a recurring grant, a reissue of a previous funding opportunity (PAR-20-043), indicating a continuous program to support the infrastructure of top cancer research institutions.	Funding Up to 1500000.00 USD Deadline Jan. 8, 2026, 10 p.m.	Details
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) PAR-25-043 Programme: National Institutes of Health (NIH)	This grant aims to support investigator-initiated research that uncovers the specific biological and molecular mechanisms by which bariatric surgery impacts cancer risk, moving beyond just weight loss outcomes. - Primarily targets research institutions and organizations with the capacity to conduct in-depth scientific studies, including universities, non-profits, and for-profit research entities. An R01 grant implies established research infrastructure. - SECTOR-SPECIFIC - Geographic scope is limited to U.S.-based applicant organizations. Foreign components or collaborators are allowed, but the lead applicant must be a U.S. entity. - Key filtering criteria include a focus on mechanistic studies, involvement of bariatric surgery and cancer risk, and exclusion of purely epidemiological or in vitro studies. Clinical trials must include a bariatric surgeon as a key investigator. - This is a recurring funding opportunity (reissue of PAR-21-331) from the National Cancer Institute (NCI) as part of NIH's broader effort to understand cancer prevention and treatment.	Funding Up to 500000.00 USD Deadline Nov. 5, 2027, 10 p.m.	Details
Boosting the attractiveness of agriculture and the connection between the farming community and society HORIZON-CL6-2025-03-GOVERNANCE-03 Programme: Horizon Europe	This grant, part of the Horizon Europe programme, aims to boost the attractiveness of agriculture and strengthen the connection between the farming community and society. The core objective is to support generational renewal, promote fair jobs, and enhance social inclusion for farmers within the context of the Common Agricultural Policy (CAP) and the Green Deal. It is a SECTOR-SPECIFIC grant primarily targeting the agriculture, bioeconomy, and related social and cultural sectors. It seeks to improve the understanding of factors influencing farming's attractiveness and develop new strategies and solutions for policymakers, businesses, and the farming community itself. Geographically, while not explicitly defined by a list of countries in the provided documents, it is part of a European Union funding program (Horizon Europe) and studies are expected to cover 'diverse regions across Europe'. This implies eligibility is typically for EU Member States and Associated Countries. Key filtering criteria for potential applicants include a focus on research and innovation (it is a Research and Innovation Action - RIA), an emphasis on social sciences and humanities (SSH) disciplines, and a willingness to engage with cultural and creative industries to improve communication about agriculture. The grant is part of a recurring call under Horizon Europe's Cluster 6.	Funding Up to 6000000.00 EUR Deadline Sept. 24, 2025, midnight	Details
Bio-fabricated materials for sustainable and beautiful construction HORIZON-NEB-2025-01-REGEN-02 Programme: Horizon Europe - New European Bauhaus Facility (NEB)	This grant, part of the New European Bauhaus initiative under Horizon Europe, aims to fund research and innovation projects focused on bio-fabricated materials for sustainable and beautiful construction. The core objective is to develop and test at least two innovative bio-fabricated construction materials that can be produced at mass-scale, are competitively priced, and meet high sustainability and aesthetic standards. This is a SECTOR-SPECIFIC grant, primarily targeting the construction and materials engineering sectors, with a strong emphasis on sustainability, circularity, and regenerative design in the built environment. While the exact geographic scope is not detailed in the provided text, it refers to Annex B of the Work Programme General Annexes for eligible countries, which typically includes EU Member States and Associated Countries. Key filtering criteria for applicants include a focus on cutting-edge bio-fabricated materials, high-tech manufacturing, and a commitment to comprehensive environmental, social, and economic impact assessments. This is a one-time call within the 2025 Work Programme for this specific topic.	Funding Up to 5000000.00 EUR Deadline Nov. 12, 2025, midnight	Details
The impact of common space on neighbourhood communities 48350050TOPICSen Programme: Horizon Europe	The grant aims to understand how the design, aesthetics, and features of common spaces impact inhabitants' behavior, health, sense of belonging, and social interactions within neighbourhood communities. It targets research and innovation actions led by various stakeholders, including public administrations, local actors, civil society, private owners, and cultural institutions. It is a SECTOR-SPECIFIC grant focused on urban development, social sciences, humanities, and participatory community engagement. The geographic scope requires projects to study common space initiatives in at least three EU Member States or Associated Countries. Key filtering criteria: Focus on community impact of common spaces, strong social sciences/humanities component, collaborative/transdisciplinary approach. This is a call within the Horizon Europe 2025 Work Programme, specifically under the New European Bauhaus Facility.	Funding Up to 3500000.00 EUR Deadline Nov. 12, 2025, midnight	Details
Support to public authorities to combat racism, xenophobia, LGBTIQ-phobia and all other forms of intolerance, including intersectional discrimination CERV-2025-EQUAL-RESTRICTED Programme: Citizens, Equality, Rights and Value Programme (CERV)	This grant, `CERV-2025-EQUAL-RESTRICTED`, aims to support public authorities in their efforts to combat racism, xenophobia, LGBTIQ-phobia, and all other forms of intolerance, including complex forms of intersectional discrimination. It is a SECTOR-SPECIFIC grant, focusing on social equality and anti-discrimination initiatives. The core objective is to fund projects that directly address these issues. The target recipients are exclusively public authorities. The geographic scope for eligible countries is not provided in this document, but is referenced as being detailed in section 6 of the call document and a list of participating countries. This grant is part of the broader Citizens, Equality, Rights and Value Programme (CERV) and is one of six priorities under a larger call for proposals for 2025, implying a recurring annual program.	Funding Up to None EUR Deadline Oct. 23, 2025, 3 p.m.	Details
Open topic on citizen and regional and/or local authorities' engagement in enhanced disaster risk awareness, including education, and preparedness HORIZON-CL3-2025-01-DRS-01 Programme: Horizon Europe	This grant, part of the Horizon Europe programme, aims to significantly enhance disaster risk awareness and preparedness among citizens and regional/local authorities across the EU and Associated Countries. It seeks proposals that will develop and implement innovative tools, solutions, or mechanisms. The core objective is to improve knowledge sharing and foster stronger cooperation between scientific communities, policy-makers, and local communities in the realm of disaster risk reduction. This grant is SECTOR-SPECIFIC, focusing entirely on civil security, disaster resilience, and crisis management. It targets consortia made up of various organizational types, including public authorities, citizen organizations, first responders, and research entities, with a mandatory geographic spread across at least three different EU Member States or Associated Countries.	Funding Up to 4000000.00 EUR Deadline Nov. 12, 2025, midnight	Details
NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) PAR-23-311 Programme: Small Business Innovation Research (SBIR) Grant	GRANT PURPOSE AND TARGET: - Single, clear statement of grant's core objective: To support Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders, focusing on Phase 1 and 2 studies to generate data for future clinical development and commercialization. - Explicit identification of target recipient type and size: United States SMEs (Small Business Concerns) with not more than 500 employees. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC - Geographic scope and any location requirements: - United States based organizations. - Clinical trials may involve single or multi-site (up to three clinical sites) within the US. - Foreign components (e.g., specific activities, collaborations) may be allowed if thoroughly justified, but foreign institutions are not eligible to apply. - Key filtering criteria for initial grant screening: - Must be a US Small Business Concern (SBC). - Must propose an exploratory clinical trial (Phase 1 or 2) in neurological disorders. - Must not be for definitive efficacy trials (e.g., Phase 3). - Must not involve more than three clinical sites. - Grant frequency and program context: - Recurring funding opportunity (multiple application deadlines until September 2026). - Part of the NIH Small Business Innovation Research (SBIR) program, designed to bridge the funding gap (Valley of Death) for regulated product development.	Funding Up to 3000000.00 USD Deadline Sept. 5, 2026, 10 p.m.	Details
Climate Governance and Information 48210274TOPICSen Programme: LIFE Climate Action - Standard Action Projects (SAP)	The core objective of this grant is to support the development, implementation, monitoring, and enforcement of the European Union's legislation and policy on climate change. It aims to contribute significantly to both climate change mitigation and adaptation efforts. Target recipient type: Public and private actors, including civil society organizations. Target recipient size: Not explicitly specified, but generally open to various organizational sizes. SECTOR-SPECIFIC Geographic scope: Eligible countries are defined in the call document, typically including EU Member States (specific list not provided). Key filtering criteria for initial screening: Projects must directly address climate change governance and information activities, contributing to EU climate policy goals. Grant frequency and program context: This call is part of the LIFE Multiannual Work Programme for 2025-2027, indicating that funding opportunities under the LIFE program are recurring, though this specific topic has a dedicated budget for 2025.	Funding Up to None EUR Deadline Sept. 23, 2025, midnight	Details
Open grounds for pre-commercial procurement of innovative security technologies HORIZON-CL3-2025-01-SSRI-03 Programme: Horizon Europe - Civil Security for Society	This grant, a 'Coordination and Support Action' (CSA), aims to lay the groundwork for a future 'Pre-Commercial Procurement' (PCP) action focusing on innovative security technologies. The core objective is to help public buyers and security end-users come together to define their common needs for new security solutions, explore available technologies, and plan for future joint procurement of research and development (R&D) services. It's a preparatory step to streamline how the EU acquires cutting-edge security innovations. This grant is SECTOR-SPECIFIC, targeting the field of civil security, including border security, fighting crime and terrorism, protecting infrastructure and public spaces, and enhancing societal resilience against disasters. It specifically targets consortia composed of public procurers and end-user organizations. The geographic scope is limited to EU Member States and Associated Countries. Key filtering criteria for this grant include the mandatory participation of a specific number of both end-user organizations and public procurers from at least three different eligible countries, and the project's focus on setting up a future PCP rather than direct technology development. This opportunity is part of the Horizon Europe Work Programme 2025, specifically under the 'Civil Security for Society' cluster, suggesting it's a recurring program, but this particular call is for the 2025 cycle.	Funding Up to 1000000.00 EUR Deadline Nov. 12, 2025, midnight	Details
Open topic on better customs and supply chain security HORIZON-CL3-2025-01-BM-03 Programme: Horizon Europe	This grant aims to significantly improve customs and supply chain security in Europe. It seeks to fund innovative solutions that help prevent, detect, deter, and combat illegal activities involving goods moving across EU external borders and through the supply chain. A core objective is to enhance interoperability while minimizing disruptions to trade flows. This opportunity is sector-specific, targeting the security, customs, and supply chain management fields. It's designed for consortia that include key public authorities. The geographic scope covers EU Member States and Associated Countries, with a particular focus on Europe's border regions. Key filtering criteria for potential applicants are the mandatory inclusion of Customs Authorities, the focus on security and supply chain innovation, and the requirement for a multi-country consortium. This grant is part of the Horizon Europe 2025 Work Programme, suggesting similar opportunities may recur.	Funding Up to 3000000.00 EUR Deadline Nov. 12, 2025, midnight	Details
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) PAR-25-188 Programme: National Institutes of Health (NIH)	• Core objective: To support the planning (UG3 phase) and implementation (UH3 phase) of well-designed, rigorously conducted behavioral and biopsychosocial intervention clinical trials. • These studies must be relevant to dental, oral, and craniofacial (DOC) health, as well as associated medical and mental health conditions or comorbidities. • Target recipient type and size: This grant targets a broad range of organizations including higher education institutions, various types of non-profits, for-profit organizations (including small businesses), and various local government and community-based entities. No specific size limits are mentioned for recipient organizations. • SECTOR-SPECIFIC: This grant is SECTOR-SPECIFIC focusing on clinical research in dental, oral, and craniofacial health. • Geographic scope: Open to domestic (U.S.) organizations only. Foreign organizations are not eligible to apply directly, but foreign components can be part of a U.S. organization's application. • Key filtering criteria: Applicants must propose an NIH-defined clinical trial focusing on behavioral/biopsychosocial interventions related to DOC health. The grant specifically excludes projects involving the testing of drugs, devices, or biologics regulated by the FDA. • Grant frequency and program context: This funding opportunity (PAR-25-188) is a reissue of a previous announcement (PAR-21-317), indicating it is a recurring program.	Funding Up to 500000.00 USD Deadline Oct. 8, 2027, 5 p.m.	Details
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) PAR-23-240 Programme: NIH Research Education Program (R25)	This grant supports educational outreach activities for health professionals, focusing on disseminating research findings related to alcohol and other substance use disorders. - It aims to improve clinical practice and patient care by enhancing healthcare providers' understanding of current research in this area. - SECTOR-SPECIFIC: Healthcare, Public Health, Research Education. - Geographic scope: Organizations located in the United States. No foreign entities or components. - Key filtering criteria: Focus on professional education, not clinical trials; specific to alcohol/substance use; U.S.-based applicant. - Grant frequency: Recurring with multiple application deadlines until May 2026; a reissue of a previous program.	Funding Up to 1080000.00 USD Deadline May 25, 2026, 9 p.m.	Details
Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS) HORIZON-JU-IHI-2025-10-02-two-stage Programme: Innovative Health Initiative Joint Undertaking (IHI JU) under Horizon Europe	Core objective: This grant aims to foster innovation in how health data is used for secondary purposes within the European Health Data Space (EHDS), ensuring strong intellectual property (IP) protection while enabling data-driven advancements in healthcare. Target recipient type and size: The opportunity targets a broad range of organizations, including public and private entities, the healthcare industry, hospitals, academic institutions, and public authorities. It is geared towards collaborative projects. MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Healthcare, Data Science, Digital Health). Geographic scope and any location requirements: Applicants must be established in EU Member States, Horizon Europe Associated Countries, or specific low- and middle-income countries. Project activities focus on improving healthcare within the EU. Key filtering criteria for initial grant screening: Focus on secondary use of health data, EHDS, data protection (IP, RDP, trade secrets), data sharing, ethical/legal standards, and fostering trust in digital health ecosystems. Grant frequency and program context: This is part of the Innovative Health Initiative Joint Undertaking (IHI JU) Call 10, which is a recurring program under Horizon Europe. This specific call operates on a two-stage application process.	Funding Up to 5200000.00 EUR Deadline Oct. 13, 2025, 10 p.m.	Details
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) PAR-25-325 Programme: National Cancer Institute (NCI) / National Institutes of Health (NIH)	Core Objective: This grant aims to support extramural research focused on investigating and mitigating challenges in clinical assay development and validation. The primary goal is to address preanalytical variability in various biospecimens (e.g., tumor tissue biopsies, liquid biopsies, bodily fluids) to achieve evidence-based standardization of biopsy handling practices. Target Recipient Type and Size: Eligible applicants include a wide range of organizations from higher education institutions and non-profits to for-profit businesses (small and large), and various governmental entities. There are no explicit organizational size limitations, but applicants must demonstrate capacity for multidisciplinary research. SECTOR-SPECIFIC: This grant is specifically focused on the HEALTHCARE sector, particularly in the area of cancer research, diagnostics, and biospecimen science. Geographic Scope: The grant is open to both domestic (U.S.) and non-domestic (non-U.S.) entities, making it a global opportunity for eligible organizations. Key Filtering Criteria: Ideal applicants will be conducting research on preanalytical variability, not developing new technologies or undertaking biomarker discovery. Projects must relate to clinical assay development and validation, and clearly demonstrate relevance to cancer clinical problems. Grant Frequency and Program Context: This is a recurring funding opportunity, listed as a reissue of PAR-22-049, with multiple application deadlines extending through September 2027. It uses a Cooperative Agreement (U01) activity code, signifying substantial programmatic involvement from the National Institutes of Health (NIH).	Funding Up to 250000.00 USD Deadline Sept. 10, 2027, 5 p.m.	Details
Networking Support Call (NSC2025) - Translational aspects of Personalised Medicine 10801COMPETITIVE_CALLen Programme: European Partnership for Personalised Medicine	Single clear statement: This grant aims to foster collaboration and accelerate the integration of personalised medicine (PM) research findings into everyday clinical practice by funding networking events for researchers and translational stakeholders. Explicit identification of target recipient type and size: The grant targets transnational consortia composed of researchers (especially those from previously funded ERA PerMed or EP PerMed projects) and various translational stakeholders (e.g., clinicians, patient advocacy groups, regulators). SECTOR-SPECIFIC Geographic scope and location requirements: The grant is for transnational European/international events. All applicants and the networking event location must be in countries participating in EP PerMed (specific countries listed in Annex 1 of the call text, not provided here). Key filtering criteria: Applicants must form a transnational consortium, include researchers from prior ERA/EP PerMed projects, focus on translational aspects of personalised medicine, and aim to organize a networking event. Grant frequency and program context: This is the 'Networking Support Call 2025' (NSC2025), suggesting it is an annual or recurring call within the broader European Partnership for Personalised Medicine (EP PerMed) program, which operates under the Horizon Europe framework.	Funding Up to 30000.00 EUR Deadline Sept. 29, 2025, noon	Details
Urban Mobility Explained (UMX) Open Call (Multi-cut-off) 11264COMPETITIVE_CALLen Programme: HORIZON-EIT-2023-25-KIC-EITURBANMOBILITY	The 'Urban Mobility Explained (UMX) Open Call' aims to fund projects that contribute to the understanding and improvement of urban mobility. This is a SECTOR-SPECIFIC grant focused solely on the urban mobility domain. - The call operates on a multi-cut-off basis, indicating recurring submission windows. - The grant falls under the broader 'HORIZON-EIT-2023-25-KIC-EITURBANMOBILITY' program, part of the EIT Urban Mobility Business Plan 2026-2028. - Target recipient type and size are not specified, suggesting a broad appeal to various entities involved in urban mobility innovation. - Geographic scope is not specified in the provided information. - Key filtering criteria for initial screening are projects directly related to urban mobility.	Funding Up to None EUR Deadline Feb. 12, 2026, 5 p.m.	Details
Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential 48340344TOPICSen Programme: Horizon Europe	Core Objective: To advance the development of antibodies and antibody-derived proteins for preventing and treating infectious diseases with epidemic potential, thereby strengthening global health security and preparedness. Target Recipient Type and Size: Primarily research and innovation entities, including universities, public bodies, and private companies. Small and Medium-sized Enterprises (SMEs) are specifically encouraged to participate. SECTOR-SPECIFIC: Health, Biotechnology, Pharmaceutical Development. Geographic Scope: Open to legal entities established in EU Member States, countries associated with Horizon Europe, and the United States of America. Participation of third countries where target viruses are endemic or have experienced outbreaks is encouraged. Key Filtering Criteria: Focus on specific viral families (Arenaviridae, Hantaviridae, Poxviridae, Paramyxo, Togaviridae), development stage (preclinical to first-in-human clinical safety studies), and the type of therapeutic (antibodies/antibody-derived proteins). Grant Frequency and Program Context: This is a single-stage call within the Horizon Europe program's 'Health' cluster for 2025, specifically under the 'Tackling diseases and reducing disease burden' destination. Horizon Europe is a recurring multi-annual funding program.	Funding Up to 10000000.00 EUR Deadline Sept. 16, 2025, midnight	Details
Tackling gender-based violence in different social and economic spheres HORIZON-CL2-2025-01-TRANSFO-01 Programme: Horizon Europe	Grant Purpose and Target Core objective: To tackle gender-based violence (GBV) in various social and economic spheres by collecting data, analyzing its prevalence and impact, and providing policymakers at regional, national, and EU levels with recommendations to address it. Target recipient types: Universities, research centers, social partners (trade unions, business organizations), civil society organizations, practitioners, VET providers, and SMEs. Grant is SECTOR-SPECIFIC focusing on Social Sciences, Gender Studies, Public Policy, Sports, Technology, and potentially Healthcare. Geographic scope: Organizations from EU Member States and Associated Countries are eligible. International cooperation is encouraged. Key filtering criteria: Projects must be research-oriented, focus on GBV within the specified areas (world of work, sports, or online platforms), and involve a collaborative consortium. Grant frequency and program context: This is part of the Horizon Europe Work Programme 2025, suggesting an annual or recurring call under this framework.	Funding Up to 3400000.00 EUR Deadline Sept. 16, 2025, midnight	Details

Minor Use Minor Species Development of Drugs (R01)

PAR-24-216

Programme: FDA Grants

This grant from the U.S. Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), aims to support research and development of new animal drugs for 'minor uses in major species' or for 'minor animal species' (MUMS drugs). It provides funding for qualified safety and effectiveness testing required for FDA approval or conditional approval of these designated veterinary drugs. - Target recipients: Institutions or organizations, or their research partners, developing MUMS animal drugs. - Target size: Not specified by size, but by role in drug development. - SECTOR-SPECIFIC: Animal Health, Veterinary Medicine, Pharmaceutical Research (Veterinary). - Geographic scope: Domestic (U.S.) and non-domestic (non-U.S.) entities are eligible. - Key filtering criteria: Must have an Investigational New Animal Drug (INAD) file with FDA/CVM, hold a MUMS 'designation' for the drug, and have FDA/CVM/ONADE concurrence on the proposed study protocol. - Grant frequency and program context: This is a recurring R01 Research Project Grant opportunity with multiple application due dates annually until January 2027. It stems from the 'Minor Use and Minor Species Animal Health Act of 2004' (MUMS Act) to increase availability of medications for less common animal health needs.

Funding

Up to 750000.00 USD

Deadline

Jan. 30, 2027, 4:59 a.m.

Details

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-21-321

Programme: P30 Center Core Grants

Grant Purpose and Target

Core Objective: Foster excellence in cancer research and facilitate the translation of scientific discoveries into improved prevention, diagnosis, and therapy by supporting NCI-designated Cancer Centers.
Target Recipient Type and Size: Established NCI-designated Cancer Centers or institutions with substantial existing cancer research funding aiming for NCI designation.
Designation: SECTOR-SPECIFIC (Healthcare/Cancer Research).
Geographic Scope and Location Requirements: Limited to institutions within the United States.
Key Filtering Criteria: Applicant must be a research institution with a significant existing base of NIH-funded cancer-focused research ($6,000,000 or $10,000,000 in direct annual costs, depending on Center type), or be an existing NCI-designated Cancer Center.
Grant Frequency and Program Context: This is a recurring grant, a reissue of a previous funding opportunity (PAR-20-043), indicating a continuous program to support the infrastructure of top cancer research institutions.

Funding

Up to 1500000.00 USD

Deadline

Jan. 8, 2026, 10 p.m.

Details

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

PAR-25-043

Programme: National Institutes of Health (NIH)

This grant aims to support investigator-initiated research that uncovers the specific biological and molecular mechanisms by which bariatric surgery impacts cancer risk, moving beyond just weight loss outcomes. - Primarily targets research institutions and organizations with the capacity to conduct in-depth scientific studies, including universities, non-profits, and for-profit research entities. An R01 grant implies established research infrastructure. - SECTOR-SPECIFIC - Geographic scope is limited to U.S.-based applicant organizations. Foreign components or collaborators are allowed, but the lead applicant must be a U.S. entity. - Key filtering criteria include a focus on mechanistic studies, involvement of bariatric surgery and cancer risk, and exclusion of purely epidemiological or in vitro studies. Clinical trials must include a bariatric surgeon as a key investigator. - This is a recurring funding opportunity (reissue of PAR-21-331) from the National Cancer Institute (NCI) as part of NIH's broader effort to understand cancer prevention and treatment.

Funding

Up to 500000.00 USD

Deadline

Nov. 5, 2027, 10 p.m.

Details

Boosting the attractiveness of agriculture and the connection between the farming community and society

HORIZON-CL6-2025-03-GOVERNANCE-03

Programme: Horizon Europe

This grant, part of the Horizon Europe programme, aims to boost the attractiveness of agriculture and strengthen the connection between the farming community and society. The core objective is to support generational renewal, promote fair jobs, and enhance social inclusion for farmers within the context of the Common Agricultural Policy (CAP) and the Green Deal. It is a SECTOR-SPECIFIC grant primarily targeting the agriculture, bioeconomy, and related social and cultural sectors. It seeks to improve the understanding of factors influencing farming's attractiveness and develop new strategies and solutions for policymakers, businesses, and the farming community itself. Geographically, while not explicitly defined by a list of countries in the provided documents, it is part of a European Union funding program (Horizon Europe) and studies are expected to cover 'diverse regions across Europe'. This implies eligibility is typically for EU Member States and Associated Countries. Key filtering criteria for potential applicants include a focus on research and innovation (it is a Research and Innovation Action - RIA), an emphasis on social sciences and humanities (SSH) disciplines, and a willingness to engage with cultural and creative industries to improve communication about agriculture. The grant is part of a recurring call under Horizon Europe's Cluster 6.

Funding

Up to 6000000.00 EUR

Deadline

Sept. 24, 2025, midnight

Details

Bio-fabricated materials for sustainable and beautiful construction

HORIZON-NEB-2025-01-REGEN-02

Programme: Horizon Europe - New European Bauhaus Facility (NEB)

This grant, part of the New European Bauhaus initiative under Horizon Europe, aims to fund research and innovation projects focused on bio-fabricated materials for sustainable and beautiful construction. The core objective is to develop and test at least two innovative bio-fabricated construction materials that can be produced at mass-scale, are competitively priced, and meet high sustainability and aesthetic standards. This is a SECTOR-SPECIFIC grant, primarily targeting the construction and materials engineering sectors, with a strong emphasis on sustainability, circularity, and regenerative design in the built environment. While the exact geographic scope is not detailed in the provided text, it refers to Annex B of the Work Programme General Annexes for eligible countries, which typically includes EU Member States and Associated Countries. Key filtering criteria for applicants include a focus on cutting-edge bio-fabricated materials, high-tech manufacturing, and a commitment to comprehensive environmental, social, and economic impact assessments. This is a one-time call within the 2025 Work Programme for this specific topic.

Funding

Up to 5000000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

The impact of common space on neighbourhood communities

48350050TOPICSen

Programme: Horizon Europe

The grant aims to understand how the design, aesthetics, and features of common spaces impact inhabitants' behavior, health, sense of belonging, and social interactions within neighbourhood communities.
It targets research and innovation actions led by various stakeholders, including public administrations, local actors, civil society, private owners, and cultural institutions.
It is a SECTOR-SPECIFIC grant focused on urban development, social sciences, humanities, and participatory community engagement.
The geographic scope requires projects to study common space initiatives in at least three EU Member States or Associated Countries.
Key filtering criteria: Focus on community impact of common spaces, strong social sciences/humanities component, collaborative/transdisciplinary approach.
This is a call within the Horizon Europe 2025 Work Programme, specifically under the New European Bauhaus Facility.

Funding

Up to 3500000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

Support to public authorities to combat racism, xenophobia, LGBTIQ-phobia and all other forms of intolerance, including intersectional discrimination

CERV-2025-EQUAL-RESTRICTED

Programme: Citizens, Equality, Rights and Value Programme (CERV)

This grant, CERV-2025-EQUAL-RESTRICTED, aims to support public authorities in their efforts to combat racism, xenophobia, LGBTIQ-phobia, and all other forms of intolerance, including complex forms of intersectional discrimination. It is a SECTOR-SPECIFIC grant, focusing on social equality and anti-discrimination initiatives. The core objective is to fund projects that directly address these issues. The target recipients are exclusively public authorities. The geographic scope for eligible countries is not provided in this document, but is referenced as being detailed in section 6 of the call document and a list of participating countries. This grant is part of the broader Citizens, Equality, Rights and Value Programme (CERV) and is one of six priorities under a larger call for proposals for 2025, implying a recurring annual program.

Funding

Up to None EUR

Deadline

Oct. 23, 2025, 3 p.m.

Details

Open topic on citizen and regional and/or local authorities' engagement in enhanced disaster risk awareness, including education, and preparedness

HORIZON-CL3-2025-01-DRS-01

Programme: Horizon Europe

This grant, part of the Horizon Europe programme, aims to significantly enhance disaster risk awareness and preparedness among citizens and regional/local authorities across the EU and Associated Countries. It seeks proposals that will develop and implement innovative tools, solutions, or mechanisms. The core objective is to improve knowledge sharing and foster stronger cooperation between scientific communities, policy-makers, and local communities in the realm of disaster risk reduction. This grant is SECTOR-SPECIFIC, focusing entirely on civil security, disaster resilience, and crisis management. It targets consortia made up of various organizational types, including public authorities, citizen organizations, first responders, and research entities, with a mandatory geographic spread across at least three different EU Member States or Associated Countries.

Funding

Up to 4000000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)

PAR-23-311

Programme: Small Business Innovation Research (SBIR) Grant

GRANT PURPOSE AND TARGET: - Single, clear statement of grant's core objective: To support Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders, focusing on Phase 1 and 2 studies to generate data for future clinical development and commercialization. - Explicit identification of target recipient type and size: United States SMEs (Small Business Concerns) with not more than 500 employees. - MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC - Geographic scope and any location requirements: - United States based organizations. - Clinical trials may involve single or multi-site (up to three clinical sites) within the US. - Foreign components (e.g., specific activities, collaborations) may be allowed if thoroughly justified, but foreign institutions are not eligible to apply. - Key filtering criteria for initial grant screening: - Must be a US Small Business Concern (SBC). - Must propose an exploratory clinical trial (Phase 1 or 2) in neurological disorders. - Must not be for definitive efficacy trials (e.g., Phase 3). - Must not involve more than three clinical sites. - Grant frequency and program context: - Recurring funding opportunity (multiple application deadlines until September 2026). - Part of the NIH Small Business Innovation Research (SBIR) program, designed to bridge the funding gap (Valley of Death) for regulated product development.

Funding

Up to 3000000.00 USD

Deadline

Sept. 5, 2026, 10 p.m.

Details

Climate Governance and Information

48210274TOPICSen

Programme: LIFE Climate Action - Standard Action Projects (SAP)

The core objective of this grant is to support the development, implementation, monitoring, and enforcement of the European Union's legislation and policy on climate change. It aims to contribute significantly to both climate change mitigation and adaptation efforts.

Target recipient type: Public and private actors, including civil society organizations.
Target recipient size: Not explicitly specified, but generally open to various organizational sizes.
SECTOR-SPECIFIC
Geographic scope: Eligible countries are defined in the call document, typically including EU Member States (specific list not provided).
Key filtering criteria for initial screening: Projects must directly address climate change governance and information activities, contributing to EU climate policy goals.
Grant frequency and program context: This call is part of the LIFE Multiannual Work Programme for 2025-2027, indicating that funding opportunities under the LIFE program are recurring, though this specific topic has a dedicated budget for 2025.

Funding

Up to None EUR

Deadline

Sept. 23, 2025, midnight

Details

Open grounds for pre-commercial procurement of innovative security technologies

HORIZON-CL3-2025-01-SSRI-03

Programme: Horizon Europe - Civil Security for Society

This grant, a 'Coordination and Support Action' (CSA), aims to lay the groundwork for a future 'Pre-Commercial Procurement' (PCP) action focusing on innovative security technologies. The core objective is to help public buyers and security end-users come together to define their common needs for new security solutions, explore available technologies, and plan for future joint procurement of research and development (R&D) services. It's a preparatory step to streamline how the EU acquires cutting-edge security innovations. This grant is SECTOR-SPECIFIC, targeting the field of civil security, including border security, fighting crime and terrorism, protecting infrastructure and public spaces, and enhancing societal resilience against disasters. It specifically targets consortia composed of public procurers and end-user organizations. The geographic scope is limited to EU Member States and Associated Countries. Key filtering criteria for this grant include the mandatory participation of a specific number of both end-user organizations and public procurers from at least three different eligible countries, and the project's focus on setting up a future PCP rather than direct technology development. This opportunity is part of the Horizon Europe Work Programme 2025, specifically under the 'Civil Security for Society' cluster, suggesting it's a recurring program, but this particular call is for the 2025 cycle.

Funding

Up to 1000000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

Open topic on better customs and supply chain security

HORIZON-CL3-2025-01-BM-03

Programme: Horizon Europe

This grant aims to significantly improve customs and supply chain security in Europe. It seeks to fund innovative solutions that help prevent, detect, deter, and combat illegal activities involving goods moving across EU external borders and through the supply chain. A core objective is to enhance interoperability while minimizing disruptions to trade flows. This opportunity is sector-specific, targeting the security, customs, and supply chain management fields. It's designed for consortia that include key public authorities. The geographic scope covers EU Member States and Associated Countries, with a particular focus on Europe's border regions. Key filtering criteria for potential applicants are the mandatory inclusion of Customs Authorities, the focus on security and supply chain innovation, and the requirement for a multi-country consortium. This grant is part of the Horizon Europe 2025 Work Programme, suggesting similar opportunities may recur.

Funding

Up to 3000000.00 EUR

Deadline

Nov. 12, 2025, midnight

Details

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-188

Programme: National Institutes of Health (NIH)

• Core objective: To support the planning (UG3 phase) and implementation (UH3 phase) of well-designed, rigorously conducted behavioral and biopsychosocial intervention clinical trials. • These studies must be relevant to dental, oral, and craniofacial (DOC) health, as well as associated medical and mental health conditions or comorbidities. • Target recipient type and size: This grant targets a broad range of organizations including higher education institutions, various types of non-profits, for-profit organizations (including small businesses), and various local government and community-based entities. No specific size limits are mentioned for recipient organizations. • SECTOR-SPECIFIC: This grant is SECTOR-SPECIFIC focusing on clinical research in dental, oral, and craniofacial health. • Geographic scope: Open to domestic (U.S.) organizations only. Foreign organizations are not eligible to apply directly, but foreign components can be part of a U.S. organization's application. • Key filtering criteria: Applicants must propose an NIH-defined clinical trial focusing on behavioral/biopsychosocial interventions related to DOC health. The grant specifically excludes projects involving the testing of drugs, devices, or biologics regulated by the FDA. • Grant frequency and program context: This funding opportunity (PAR-25-188) is a reissue of a previous announcement (PAR-21-317), indicating it is a recurring program.

Funding

Up to 500000.00 USD

Deadline

Oct. 8, 2027, 5 p.m.

Details

Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)

PAR-23-240

Programme: NIH Research Education Program (R25)

This grant supports educational outreach activities for health professionals, focusing on disseminating research findings related to alcohol and other substance use disorders. - It aims to improve clinical practice and patient care by enhancing healthcare providers' understanding of current research in this area. - SECTOR-SPECIFIC: Healthcare, Public Health, Research Education. - Geographic scope: Organizations located in the United States. No foreign entities or components. - Key filtering criteria: Focus on professional education, not clinical trials; specific to alcohol/substance use; U.S.-based applicant. - Grant frequency: Recurring with multiple application deadlines until May 2026; a reissue of a previous program.

Funding

Up to 1080000.00 USD

Deadline

May 25, 2026, 9 p.m.

Details

Safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)

HORIZON-JU-IHI-2025-10-02-two-stage

Programme: Innovative Health Initiative Joint Undertaking (IHI JU) under Horizon Europe

Core objective: This grant aims to foster innovation in how health data is used for secondary purposes within the European Health Data Space (EHDS), ensuring strong intellectual property (IP) protection while enabling data-driven advancements in healthcare.
Target recipient type and size: The opportunity targets a broad range of organizations, including public and private entities, the healthcare industry, hospitals, academic institutions, and public authorities. It is geared towards collaborative projects.
MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Healthcare, Data Science, Digital Health).
Geographic scope and any location requirements: Applicants must be established in EU Member States, Horizon Europe Associated Countries, or specific low- and middle-income countries. Project activities focus on improving healthcare within the EU.
Key filtering criteria for initial grant screening: Focus on secondary use of health data, EHDS, data protection (IP, RDP, trade secrets), data sharing, ethical/legal standards, and fostering trust in digital health ecosystems.
Grant frequency and program context: This is part of the Innovative Health Initiative Joint Undertaking (IHI JU) Call 10, which is a recurring program under Horizon Europe. This specific call operates on a two-stage application process.

Funding

Up to 5200000.00 EUR

Deadline

Oct. 13, 2025, 10 p.m.

Details

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

PAR-25-325

Programme: National Cancer Institute (NCI) / National Institutes of Health (NIH)

Core Objective: This grant aims to support extramural research focused on investigating and mitigating challenges in clinical assay development and validation. The primary goal is to address preanalytical variability in various biospecimens (e.g., tumor tissue biopsies, liquid biopsies, bodily fluids) to achieve evidence-based standardization of biopsy handling practices.
Target Recipient Type and Size: Eligible applicants include a wide range of organizations from higher education institutions and non-profits to for-profit businesses (small and large), and various governmental entities. There are no explicit organizational size limitations, but applicants must demonstrate capacity for multidisciplinary research.
SECTOR-SPECIFIC: This grant is specifically focused on the HEALTHCARE sector, particularly in the area of cancer research, diagnostics, and biospecimen science.
Geographic Scope: The grant is open to both domestic (U.S.) and non-domestic (non-U.S.) entities, making it a global opportunity for eligible organizations.
Key Filtering Criteria: Ideal applicants will be conducting research on preanalytical variability, not developing new technologies or undertaking biomarker discovery. Projects must relate to clinical assay development and validation, and clearly demonstrate relevance to cancer clinical problems.
Grant Frequency and Program Context: This is a recurring funding opportunity, listed as a reissue of PAR-22-049, with multiple application deadlines extending through September 2027. It uses a Cooperative Agreement (U01) activity code, signifying substantial programmatic involvement from the National Institutes of Health (NIH).

Funding

Up to 250000.00 USD

Deadline

Sept. 10, 2027, 5 p.m.

Details

Networking Support Call (NSC2025) - Translational aspects of Personalised Medicine

10801COMPETITIVE_CALLen

Programme: European Partnership for Personalised Medicine

Single clear statement: This grant aims to foster collaboration and accelerate the integration of personalised medicine (PM) research findings into everyday clinical practice by funding networking events for researchers and translational stakeholders.
Explicit identification of target recipient type and size: The grant targets transnational consortia composed of researchers (especially those from previously funded ERA PerMed or EP PerMed projects) and various translational stakeholders (e.g., clinicians, patient advocacy groups, regulators).
SECTOR-SPECIFIC
Geographic scope and location requirements: The grant is for transnational European/international events. All applicants and the networking event location must be in countries participating in EP PerMed (specific countries listed in Annex 1 of the call text, not provided here).
Key filtering criteria: Applicants must form a transnational consortium, include researchers from prior ERA/EP PerMed projects, focus on translational aspects of personalised medicine, and aim to organize a networking event.
Grant frequency and program context: This is the 'Networking Support Call 2025' (NSC2025), suggesting it is an annual or recurring call within the broader European Partnership for Personalised Medicine (EP PerMed) program, which operates under the Horizon Europe framework.

Funding

Up to 30000.00 EUR

Deadline

Sept. 29, 2025, noon

Details

Urban Mobility Explained (UMX) Open Call (Multi-cut-off)

11264COMPETITIVE_CALLen

Programme: HORIZON-EIT-2023-25-KIC-EITURBANMOBILITY

The 'Urban Mobility Explained (UMX) Open Call' aims to fund projects that contribute to the understanding and improvement of urban mobility. This is a SECTOR-SPECIFIC grant focused solely on the urban mobility domain. - The call operates on a multi-cut-off basis, indicating recurring submission windows. - The grant falls under the broader 'HORIZON-EIT-2023-25-KIC-EITURBANMOBILITY' program, part of the EIT Urban Mobility Business Plan 2026-2028. - Target recipient type and size are not specified, suggesting a broad appeal to various entities involved in urban mobility innovation. - Geographic scope is not specified in the provided information. - Key filtering criteria for initial screening are projects directly related to urban mobility.

Funding

Up to None EUR

Deadline

Feb. 12, 2026, 5 p.m.

Details

Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

48340344TOPICSen

Programme: Horizon Europe

Core Objective: To advance the development of antibodies and antibody-derived proteins for preventing and treating infectious diseases with epidemic potential, thereby strengthening global health security and preparedness.
Target Recipient Type and Size: Primarily research and innovation entities, including universities, public bodies, and private companies. Small and Medium-sized Enterprises (SMEs) are specifically encouraged to participate.
SECTOR-SPECIFIC: Health, Biotechnology, Pharmaceutical Development.
Geographic Scope: Open to legal entities established in EU Member States, countries associated with Horizon Europe, and the United States of America. Participation of third countries where target viruses are endemic or have experienced outbreaks is encouraged.
Key Filtering Criteria: Focus on specific viral families (Arenaviridae, Hantaviridae, Poxviridae, Paramyxo, Togaviridae), development stage (preclinical to first-in-human clinical safety studies), and the type of therapeutic (antibodies/antibody-derived proteins).
Grant Frequency and Program Context: This is a single-stage call within the Horizon Europe program's 'Health' cluster for 2025, specifically under the 'Tackling diseases and reducing disease burden' destination. Horizon Europe is a recurring multi-annual funding program.

Funding

Up to 10000000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

Tackling gender-based violence in different social and economic spheres

HORIZON-CL2-2025-01-TRANSFO-01

Programme: Horizon Europe

Grant Purpose and Target

Core objective: To tackle gender-based violence (GBV) in various social and economic spheres by collecting data, analyzing its prevalence and impact, and providing policymakers at regional, national, and EU levels with recommendations to address it.
Target recipient types: Universities, research centers, social partners (trade unions, business organizations), civil society organizations, practitioners, VET providers, and SMEs.
Grant is SECTOR-SPECIFIC focusing on Social Sciences, Gender Studies, Public Policy, Sports, Technology, and potentially Healthcare.
Geographic scope: Organizations from EU Member States and Associated Countries are eligible. International cooperation is encouraged.
Key filtering criteria: Projects must be research-oriented, focus on GBV within the specified areas (world of work, sports, or online platforms), and involve a collaborative consortium.
Grant frequency and program context: This is part of the Horizon Europe Work Programme 2025, suggesting an annual or recurring call under this framework.

Funding

Up to 3400000.00 EUR

Deadline

Sept. 16, 2025, midnight

Details

You can filter by below criteria

Grants